姓名：赵赋 性别：男 职称：副教授
招生类型：科学学位(硕)
招生专业：外科学（神外）(硕)
研究方向：脑肿瘤综合治疗的基础与临床转化研究
电子信箱：zhaofu1024@126.com
社会任职
1. 中国抗癌协会神经肿瘤专业委员会青年委员
2. 北京抗癌协会神经肿瘤专业委员会青年委员
个人简历
1. 202201- :首都医科大学 副教授
2. 201812- :北京市神经外科研究所 副研究员
3. 201507-201906:北京大学 学习
4. 201301-201811:北京市神经外科研究所 助理研究员，医师
5. 200908-201212:北京市神经外科研究所 实习研究员，医师
6. 200208-200907:首都医科大学 临床医学7年制
重要学术论文
1. Fu Zhao, Shi-wei Li #, Shun Zhang, Peng Li, Chi Zhao., Xiao-bin Zhao, Chun-Hong Wang, Jing Zhang, Bo Wang, Pi-nan Liu*.Phase II trial of icotinib in adult patients with neurofibromatosis type 2 and progressive vestibular schwannoma.Journal of Neurosurgery.2022.10.1-8.SCI
2. 5. Zhi-ming Liu, Zhe Han, Jun-mei Wang, Tao Sun, Wei Liu, Bo Li, Jian Gong, Chun-de Li*, Fu Zhao*, Yong-ji Tian*.Treatment and outcome of pediatric intracranial ependymoma after first relapse.Journal Neuro-Oncology.2022.157(3).385-396.SCI
3. Fu Zhao *, Yang Chen, Shi-Wei Li, Jing Zhang, Shun Zhang, Xiao-Bin Zhao, Zhi-Jun Yang, Bo Wang, Qi-Yang He, Lei-Ming Wang, Lei Xu, and Pi-Nan Liu *.Novel Patient-Derived Xenograft and Cell Line models for Therapeutic Screening in NF2-associated Schwannoma.Journal of Pathology.2022.257(5).620-634.SCI
4. Jie Lin #, Shi-wei Li #, Jing Zhang, Fu-hao Chu, Cheng-ze Li, Zhi-xu Bie, Han-lu Tang, Shan Gao, Ping Li, Meng-ting Liao, Tian-xi Xin, Fu Zhao *, Pi-nan Liu * and Xia Ding *.Qu-Du-San-Jie Decoction Induces Growth Inhibition and Vascular Normalization in NF2-Associated Vestibular Schwannoma.Frontiers in Pharmacology.2022.13.941854.SCI
5. 2Zhi-Wei Zhang #, Xufei Teng #, Fu Zhao #, Chunhui Ma #, Jing Zhang, Mengqi Chang, Yongji Tian, Chunde Li, Zhang Zhang, Shuhui Song *, Yamei Niu *, Pinan Liu *, Wei-Min Tong *.METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.Cell Reports.2022.41(4).111530.SCI
6. Fu Zhao#, Zhi-Wei Zhang#, Jing Zhang , Shun Zhang, Heng Zhang , Chi Zhao, Yang Chen , Lin Luo , Wei-Min Tong, Chunde Li , Yamei Niu* and Pinan Liu*. Loss of 5-hydroxymethylcytosine as an epigenetic signature that correlates with poor outcomes in patients with medulloblastoma. Frontier in Oncology.2021.11.603686.SCI
7. Shi-wei Li, Jing Zhang, Han-lu Tang, Peng Li, Bo Wang, Fu Zhao*, Pinan Liu*.Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.Journal of Neuro-Oncology.2021.155(3).373–381.SCI
8. 赵赋，王博，李仕维，王兴朝，张晶，王振民，李朋，杨智君，刘丕楠*.应用国产化多通道听觉脑干植入设备重建2型神经纤维瘤病患者听觉功能的临床试验研究.中华神经外科杂志.2021.37(4).369-374.核心期刊
9. Fu Zhao#, Tao Wu#, Lei-ming Wang, Jing Zhang, Heng Zhang, Shi-wei Li, Shun Zhang, Peng Li, Bo Wang, Lin Luo, and Pi-nan Liu*.Survival and prognostic factors of adult intracranial ependymoma: A single-institutional analysis of 236 patients.American Journal of Surgical Pathology.2021.45(7). 979-987.SCI
10. Tao Wu, Zhi-Wei Zhang, Shiwei Li, Bo Wang, Zhijun Yang, Peng Li, Jing Zhang, Wei-Min Tong, Chunde Li, Fu Zhao, Yamei Niu*, Pinan Liu*. Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma.Clin Epigenetics.2020.12(1).19.SCI
11. 7. Tao Wu, Pei-ran Qu, Shun Zhang, Shi-wei Li, Jing Zhang, Bo Wang, Pinan Liu, Chun-de Li, Fu Zhao*.The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.Scientific Reports.2020.10.9769.SCI
12. 张晶，杨智君，张顺，陈震，赵赤，吴涛，王博，刘丕楠，赵赋*.小脑脑桥角区恶性周围神经鞘瘤的临床和病理学特征分析.中华神经外科杂志.2019.35 (5).448-453.核心期刊
13. 吴涛，刘丕楠，赵赋*.室管膜瘤分子生物学的研究进展.中华神经外科杂志.2019.35 (2).207-209.核心期刊
14. Fu Zhao, Shun Zhang, Jiang Du, Yang Chen, Bo Wang, Jing Zhang, Qiyang He, Luo Lin, Li Zhang, Yanbing Yu, Pinan Liu*.Comparison of Clinical, Histopathological, and Genomic Features Between Malignant Peripheral Nerve Sheath Tumors and Cellular Schwannomas of the Eighth Cranial Nerve: A Case Series.World Neurosurgery.2019.122.e487-e497.SCI
15. Fu Zhao*, Bo Wang, Zhijun Yang, Qiangyi Zhou, Peng Li, Xingchao Wang, Jing Zhang, Junting Zhang, Pinan Liu*.Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.Journal of Neuro-Oncology.2018.139(2).333–340.SCI
16. 赵赋，张晶，李春德*.髓母细胞瘤的分子生物学研究进展.中华神经外科杂志.2018.34 (12).1287-1290.核心期刊
17. Fu Zhao*, Bo Wang, Zhijun Yang, Qiangyi Zhou, Peng Li, Xingchao Wang, Jing Zhang, Junting Zhang, Pinan Liu*.Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation..Journal of Neuro-Oncology.2018.138 (2).417–424.SCI
18. 13. Qiangyi Zhou (#), Zhijun Yang, Zhenmin Wang, Bo Wang, Xingchao Wang, Chi Zhao, Shun Zhang, Tao Wu, Peng Li, Shiwei Li, Fu Zhao*, Pinan Liu*.Awake craniotomy for assisting placement of auditory brainstem implant in NF2 patients.ACTA OTO-LARYNGOLOGICA.2018.138(6).548–553.SCI
19. 张顺，刘丕楠，赵赋*.神经鞘瘤的分子遗传学研究进展.中华神经外科杂志.2017.33(9).966-969.核心期刊
20. 赵赤，刘丕楠，赵赋*.脑膜瘤的分子生物学研究进展.中华神经外科杂志.2017.33(2).202-205.核心期刊
21. Li P, Yang Z, Wang Z, Zhou Q, Li S, Wang X, Wang B, Zhao F, Liu P.Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution.Acta Neurochir (Wien).2016.158(1).67–76.SCI
22. 叶建忠，刘丕楠，李朋，杨智君，王博，张晶，赵赋*.成人髓母细胞瘤分子亚型的临床及病理学特点分析.中华神经外科杂志.2016.32 (1).21-24.核心期刊
23. 赵赋，李朋，张晶，杲新晴，杨智君，王博，王兴朝，王振民，刘丕楠*.遗传性2型神经纤维瘤病家系基因突变及临床特点分析.中华神经外科杂志.2016.32(1).3-7.核心期刊
24. Wang X, Xu P, Li P, Wang Z, Zhao F, Gao Z, Xu L, Luo YJ, Fan J, Liu Pinan*.Alterations in gray matter volume due to unilateral hearing loss.Scientific Reports.2016.6.25811.SCI
25. Zhao F#, Ohgaki H, Xu L, Giangaspero F, Li C, Li P, Yang Z, Wang B, Wang X, Wang Z, Ai L, Zhang J, Luo L, Liu P*.Molecular subgroups of adult medulloblastoma: a long-term single-institution study.Neuro-Oncology.2016.18 (7).982-990.SCI
26. 张晶, 李春德, 刘丕楠, 李朋, 李仕维, 张顺, 赵赤, 赵赋*. 实时荧光定量PCR确定儿童和青少年髓母细胞瘤分子亚型的准确性分析.中华神经外科杂志.2016.32 (9).867–872.核心期刊
27. 李仕维, 刘丕楠, 周强意, 张晶, 张顺, 杨智君, 王博, 赵赋*.大鼠坐骨神经移植神经鞘瘤模型的建立.中华神经外科杂志.2016.32(9).1151–1155.核心期刊
28. 赵赋，武丽，王博，杨智君，王振民，王兴朝，李朋，张晶，刘丕楠*.听性脑干反应和纯音听阈在听神经瘤早期诊断中的应用.中华神经外科杂志.2015.31(7).672–675.核心期刊
29. 赵赋，王博，杨智君，王振民，吴胜田，李智，张晶，汪颖，王兴朝，刘丕楠*.2型神经纤维瘤病前庭神经鞘瘤的显微外科治疗.中华神经外科杂志.2014.30(11).1153–1156.核心期刊
30. 14. 赵赋，李进军，张晶，王兴朝，王振民，渠沛然，罗麟，刘丕楠*.成人髓母细胞瘤不同病理亚型临床特征及预后分析.中华病理学杂志.2014. 31(2).169–172.核心期刊
31. 赵赋，渠沛然，张晶，王振民，王兴朝，杨智君，刘丕楠*.成人髓母细胞瘤的临床治疗及预后.中华神经科杂志.2013.46(7).1–5.核心期刊
32. 赵赋，王博，杨智君，吴胜田，王振民，张晶，刘丕楠*.内镜下经鼻入路治疗颅底中央区恶性肿瘤.中国微侵袭神经外科杂志.2013. 18 (5).193–196.核心期刊
33. 赵赋; 张晶;汪颖; 杨智君; 王博; 王兴朝; 王振民; 渠沛然; 李朋; 刘丕楠*.2型神经纤维瘤病患者临床各因素与预后相关性分析.中华神经外科杂志.2013.29(10).980–983.核心期刊
34. 赵赋，张玉琪，王振民，王小平，杨智君，罗麟，Felice Giangaspero，刘丕楠*.促纤维增生／结节型髓母细胞瘤病理学特点及相关信号通路研究.中华神经外科杂志.2012.28(10).1040–1044.核心期刊
主编或副主编的著作/译著
重要奖项
1. 2型神经纤维瘤病临床诊疗体系的建立与应用推广 科技进步奖 二等奖 202212
2. 新的人源NF2神经鞘瘤移植瘤及细胞系模型建立及应用 2022世界神经肿瘤大会（WFNOS）最佳摘要奖 202204
3. 神经内镜微创治疗颅底病变 国家教育部科技进步奖 贰等奖 2011
